Pediatric Anaphylaxis in Emergency Care: A Detailed Analysis of Demographic and Laboratory Findings

Nilay Caliskan1, Recep Okur2, Alper Kacar3

  • 1Department of Pediatric Allergy and Immunology, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Türkiye.

Sisli Etfal Hastanesi Tip Bulteni
|February 17, 2026
PubMed

Insights

Pediatric anaphylaxis is a serious allergic reaction, often triggered by medications or food like cow's milk. This study highlights key demographic and clinical findings, emphasizing the need for prompt recognition and treatment by physicians.

Area of Science:

  • Pediatric Emergency Medicine
  • Allergy and Immunology
  • Clinical Pediatrics

Background:

  • Anaphylaxis is a severe, life-threatening systemic allergic reaction with increasing incidence.
  • Prompt recognition and management in pediatric emergency departments (PEDs) are critical.
  • Understanding demographic and clinical patterns aids in effective treatment strategies.

Purpose of the Study:

  • To analyze the demographic, clinical, and laboratory characteristics of pediatric patients diagnosed with anaphylaxis.
  • To identify common triggers and affected systems in pediatric anaphylaxis cases.
  • To evaluate tryptase levels in relation to anaphylaxis type and age groups.

Main Methods:

  • Retrospective review of 100 pediatric patients diagnosed with anaphylaxis between 2016 and 2023.
  • Data collection included patient demographics, trigger identification, affected systems, and tryptase levels.
  • Statistical analysis was performed to examine relationships between variables.

Main Results:

  • The majority of patients (72%) were over 6 years old, with anaphylaxis most frequently occurring at home (83%).
  • Medications were the most common trigger (81%), followed by food (e.g., cow's milk in 8%).
  • Skin and mucosa were the most affected systems (97%), and idiopathic cases showed higher average tryptase levels (9.15 ug/L).

Conclusions:

  • Anaphylaxis management requires rapid and accurate intervention, with adrenaline as the primary treatment.
  • Pediatric emergency physicians are vital in managing anaphylaxis.
  • Observed pediatric tryptase levels were often below established cut-offs, suggesting a need for further research to redefine reference ranges.
Abstract

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
21
Allergic Reactions02:06

Allergic Reactions

Overview
32.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
341
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
337
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
324